Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Non-Current Debt (2025 - 2026)

Updated

Moderna (MRNA) recorded Non-Current Debt of $591 million in Q2 2026, up 0.2% from the prior quarter.

Analysis

Moderna (MRNA) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Moderna reported Non-Current Debt of $590 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 37.34 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 62.48 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 23.68 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 23.83 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 60.50 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 591.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 591.00 Mn
Mar 31, 2026 590.00 Mn
Dec 31, 2025 590.00 Mn
API Access

Moderna Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=MRNA&period=max&api_key=YOUR_API_KEY